Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
21 Décembre 2023 - 10:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒
Filed by a party other than the Registrant ☐
CHECK THE APPROPRIATE BOX:
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional Materials |
☐ |
Soliciting Material under § 240.14a-12 |
Assembly Biosciences, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY):
☐ |
Fee paid previously with preliminary materials |
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(1) and 0-11 |
You invested in ASSEMBLY BIOSCIENCES, INC. and its time to vote!
You have the right to vote on proposals being presented at the Special Meeting. This is an important notice regarding the
availability of proxy material for the stockholder meeting to be held on January 31, 2024.
Get informed before you vote
View the Notice and Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to
January 17, 2024. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not
otherwise receive a paper or email copy.
*Please check the meeting materials for
any special requirements for meeting attendance.
V1.1
Vote at www.ProxyVote.com
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the
upcoming stockholder meeting.
Please follow the instructions on
the reverse side to vote these important matters.
|
|
|
|
|
|
|
Voting Items |
|
Board
Recommends |
|
|
|
|
1. |
|
Approval of a series of alternative amendments to our Sixth Amended and Restated Certificate of Incorporation to effect, at the discretion of our
Board of Directors, a reverse stock split of our common stock at a ratio to be determined by the Board within a range of 1-for-7 to 1-for-17 (or any number in between) without reducing the authorized number of shares of the common stock. |
|
|
|
For |
|
|
|
|
2. |
|
Approval, subject to certain conditions, the issuance of shares of common stock to Gilead Sciences, Inc. pursuant to Nasdaq Listing Rules 5635(a) and
5635(b). |
|
|
|
For |
|
|
|
|
3. |
|
Approval of an adjournment of the Special Meeting to a later date or dates, if necessary, to solicit additional proxies if there are not sufficient
votes in favor of the foregoing proposals. |
|
|
|
For |
|
|
|
NOTE: Your proxy holder will
also vote in their discretion upon such other matters that may properly come before the meeting and any adjournment or postponement thereof. |
|
|
|
|
|
|
|
|
|
|
|
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click Delivery Settings. |
V27120-S77938
Assembly Biosciences (NASDAQ:ASMB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Assembly Biosciences (NASDAQ:ASMB)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024